Last Thursday, April 13, 2017, we published our findings on why we are very bearish on Great Basin Scientific (OTC:GBSN) (GBSND), a company that describes itself as a molecular diagnostics company. We commented on what we perceive as a series of bad […]
Great Basin Scientific put out a press release this morning detailing a $5M NIH grant that it received in conjunction with Brigham Young University. The release reads: The National Institute of Allergy and Infectious Diseases, part of the National Institutes […]
According to the Company’s 8-K filed on June 23, 2015, Great Basin Scientific amended and restated the terms governing the Series C Warrants and Series E Convertible Preferred Stock issued by the Company. We believe that holders of these warrants […]
Documents filed by Great Basin Scientific (GBSN) offer insight on potential stock dilution that is on the way. On April 20 and 22, 2015 the company filed a series of 424(B)(3) prospectuses detailing the circumstances that would allow 32 million shares […]
Yesterday, the company filed an 8-K indicating that a $500k convertible promissory note term issued to the company, at 20% per annum, from its Chairman of the Board had been extended for an additional year. The cost to extend the […]
GeoInvesting believes Great Basic Scientific’s (GBSN) stock price spike is unwarranted. This gives us more of a reason to remain short the stock as we feel that its price will retrace back to realistic levels. Great Basin is a rapid […]
GeoInvesting is currently short Great Basic Scientific (GBSN), a rapid diagnostic medical test (Nucleic Acid Assay Testing) firm. We first alerted GeoInvesting premium members that we identified red flags associated with GBSN on March 30, 2015. In our March 30 e-mail to […]
On March 30, 2014 GeoInvesting stated that it was taking a closer look at Great Basin Scientific (GBSN) as just 3 months after the company went public on October 9, 2014, we received a promotional pump, e-mail newsletter. The day of […]